Childhood cancers trials in Canada

In Canada 154 Also abroad 2481

154 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
Study of Out of Specification for Tisagenlecleucel
Where
Hamilton, Montreal, Ottawa, Québec, Toronto
Age
0 years to 100 years
People
200 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT04094311
No phaseTaking people
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
Where
Montreal, Toronto
Age
Up to 17 years
People
1,600 worldwide
Run by
M.D. Anderson Cancer Center
See details and how to joinNCT06651580
Phase 3Taking people
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
Where
Edmonton, London, Montreal, Toronto
Age
12 years to 100 years
People
240 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06784752 · EU 2024-518325-15-00
Phase 2Taking people
Radiotherapy to Consolidate Systemic Response in Metastatic Prostate Cancer (ANCHOR-Prostate)
Where
Montreal
People
80
Run by
Centre hospitalier de l'Université de Montréal (CHUM)
See details and how to joinNCT05457699
No phaseTaking people
Targeted Pediatric High-Grade Glioma Therapy
Where
Montreal, Toronto
Age
12 months to 39 years
People
350 worldwide
Run by
Nationwide Children's Hospital
See details and how to joinNCT05839379
Phase 2/3Taking people
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
Where
Calgary, Montral, Montreal, Toronto, Vancouver, Winnipeg
Age
1 month to 18 years
People
1,800 worldwide
Run by
St. Anna Kinderkrebsforschung
See details and how to joinNCT01949129 · EU 2024-512657-24-00
Phase 2Taking people
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Where
Calgary, Montreal, Québec, Sherbrooke
Age
Up to 22 years
People
500 worldwide
Run by
Giselle Sholler
See details and how to joinNCT02559778
Phase 2Taking people
Study of Olutasidenib and Temozolomide in HGG
Where
Montreal, Toronto
Age
12 years to 39 years
People
60 worldwide
Run by
Rigel Pharmaceuticals
See details and how to joinNCT06161974
Phase 2Taking people
External Beam and Radioligand Radiotherapy for mCRPC
Where
Montreal
People
120
Run by
Centre hospitalier de l'Université de Montréal (CHUM)
See details and how to joinNCT07354594
Phase 3Taking people
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Where
Montreal, Québec, Sherbrooke, Winnipeg
Age
Up to 39 years
People
60 worldwide
Run by
Children's Oncology Group
See details and how to joinNCT06513962
No phaseTaking people
Project: Every Child for Younger Patients With Cancer
Where
Calgary, Edmonton, Halifax, Hamilton, Kingston, London, Montreal, Ottawa, Québec, Saskatoon, Sherbrooke, St. John's, Toronto, Vancouver, Winnipeg
Age
Up to 25 years
People
75,000 worldwide
Run by
Children's Oncology Group
See details and how to joinNCT02402244
Phase 3Taking people
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
Where
Calgary, Edmonton, Halifax, Hamilton, Kingston, London, Montreal, Ottawa, Québec, Sherbrooke, St. John's, Toronto, Vancouver, Winnipeg
People
1,780 worldwide
Run by
Children's Oncology Group
See details and how to joinNCT03067181
Phase 3Taking people
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Where
Halifax, Hamilton, Kingston, London, Montreal, Ottawa, Québec, St. John's, Toronto, Vancouver, Winnipeg
Age
365 days to 30 years
People
750 worldwide
Run by
Children's Oncology Group
See details and how to joinNCT03126916
Phase 3Taking people
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Where
Calgary, Edmonton, Halifax, Hamilton, Kingston, London, Montreal, Ottawa, Québec, Saskatoon, Sherbrooke, St. John's, Toronto, Vancouver, Winnipeg
Age
365 days to 25 years
People
5,951 worldwide
Run by
Children's Oncology Group
See details and how to joinNCT03959085
Phase 2Taking people
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Where
Calgary, Edmonton, Halifax, Hamilton, London, Montreal, Ottawa, Québec, Sherbrooke, St. John's, Toronto, Vancouver, Winnipeg
Age
Up to 30 years
People
256 worldwide
Run by
Children's Oncology Group
See details and how to joinNCT04322318
Phase 1/2Taking people
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Where
Calgary, Edmonton, Halifax, London, Montreal, Ottawa, Québec, Sherbrooke, Toronto, Vancouver, Winnipeg
Age
Up to 22 years
People
960 worldwide
Run by
PedAL BCU, LLC
See details and how to joinNCT04726241
Phase 3Taking people
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Where
Calgary, Edmonton, Halifax, Montreal, Sherbrooke
Age
Up to 50 years
People
62 worldwide
Run by
Children's Oncology Group
See details and how to joinNCT05235165
Phase 3Taking people
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
Where
Calgary, Edmonton, Halifax, Montreal, Québec, Sherbrooke, Toronto, Vancouver, Winnipeg
Age
Up to 21 years
People
205 worldwide
Run by
Children's Oncology Group
See details and how to joinNCT05304585
Phase 3Taking people
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Where
Halifax, Montreal, Québec, Sherbrooke, Winnipeg
Age
4 years to 21 years
People
225 worldwide
Run by
Children's Oncology Group
See details and how to joinNCT05382338
Phase 2Taking people
A Study to Give Treatment Inside the Eye to Treat Retinoblastoma
Where
Montreal
Age
Up to 18 years
People
26 worldwide
Run by
Children's Oncology Group
See details and how to joinNCT05504291
No phaseTaking people
A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
Where
London
Age
6 years to 39 years
People
330 worldwide
Run by
Children's Oncology Group
See details and how to joinNCT05702645
No phaseTaking people
A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma
Where
Toronto
Age
7 years and over
People
190 worldwide
Run by
Children's Oncology Group
See details and how to joinNCT05705531
Phase 2Taking people
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Where
Edmonton, Halifax, Hamilton, London, Montreal, Québec, Sherbrooke, Toronto, Vancouver, Winnipeg
Age
3 years to 29 years
People
240 worldwide
Run by
Children's Oncology Group
See details and how to joinNCT06368817
Phase 3Taking people
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
Where
Calgary, Edmonton, Halifax, Hamilton, London, Montreal, Ottawa, Québec, Sherbrooke, Toronto, Winnipeg
Age
Up to 30 years
People
1,656 worldwide
Run by
Children's Oncology Group
See details and how to joinNCT06401330
Phase 3Taking people
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
Where
Halifax, Montreal, Québec, Sherbrooke, Toronto, Winnipeg
Age
Up to 21 years
People
110 worldwide
Run by
Children's Oncology Group
See details and how to joinNCT06647953